Vascular mechanisms of post-COVID-19 conditions: Rho-kinase is a novel target for therapy.
Sykes RA, Neves KB, Alves-Lopes R, Caputo I, Fallon K, Jamieson NB, Kamdar A, Legrini A, Leslie H, McIntosh A, McConnachie A, Morrow A, McFarlane RW, Mangion K, McAbney J, Montezano AC, Touyz RM, Wood C, Berry C.
Sykes RA, et al. Among authors: leslie h.
Eur Heart J Cardiovasc Pharmacother. 2023 Jun 2;9(4):371-386. doi: 10.1093/ehjcvp/pvad025.
Eur Heart J Cardiovasc Pharmacother. 2023.
PMID: 37019821
Free PMC article.